Matrix Capital Management Company, LP Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001410830
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2024 · 23 positions · Total reported value $13.14B · Top-10 concentration 94.7% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 50.0% · 0 new · 0 cut · 1 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
In its Q2 2024 13F filing, Matrix Capital Management Company, LP disclosed 23 equity positions with a combined reported value of $13.14B. The filing implies a focused portfolio: its ten largest positions account for 94.7% of reported value. HoldingsHub classifies the profile as Large / Focused / Technology Tilt / High Turnover.
The largest disclosed positions as of Q2 2024 were NVDA ($3.28B), QCOM ($1.99B), TDG ($1.40B). By sector, the heaviest allocations are Technology 70.4%, Industrials 11.1%. Versus the prior quarter, allocation shifted toward Technology (+5.6pp) and away from Consumer Discretionary (-0.5pp), Industrials (-1.9pp).
Versus the prior quarter, Matrix Capital Management Company, LP opened 0 new positions, trimmed 0 and fully exited 1, a turnover rate of 50.0% of positions. The portfolio's overlap with the prior quarter was 84% of names.
The largest new positions opened in Q2 2024 were OKTA ($53.83M), GERN ($2.42M).
Of the 1 positions fully exited versus the prior quarter, the largest were MRNA ($77.79M), PTC ($56.08M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2024)
- OKTA OKTA INC · $53.83M
- GERN GERON CORP COM · $2.42M
Insider Transactions (Form 4)
Latest Matrix Capital Management Company, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-05-07 | Sell | Aura Biosciences, Inc. | 6,922,870 | $5.64 | SEC filing |
Fund Profile
Matrix Capital Management Company, LP is an SEC-registered 13F filer based in Portsmouth, NH, United States. As of Q1 2026 it reported 1 US equity positions with a combined value of $46.31M. HoldingsHub carries 11 quarters of its filings (Q3 2023–Q1 2026).
Firm Snapshot
- Headquarters: PORTSMOUTH, NH, United States
- SEC registration: 801-73612 (status: Approved), registered 2012-03-30
- Regulatory AUM (Form ADV): $2.32B as of 2026-03-31
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 2 private funds, of which 1 hedge funds
Portfolio Structure
- 1 positions · $46.31M reported value (Q1 2026)
- Top 10 holdings = 100.0% of reported value
- Largest position: AURA (AURA BIOSCIENCES INC) at 100.0%
- Average position size: $46.31M
Sector Tilt
- Health Care 100.0%
- (classified holdings cover 100% of value)
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
26.59M | $3.28B | 25.00% | Add | |
| 2 |
|
10.00M | $1.99B | 15.16% | Add | |
| 3 |
|
1.09M | $1.40B | 10.65% | Hold | |
| 4 |
|
12.43M | $1.22B | 9.28% | Hold | |
| 5 |
|
15.06M | $1.05B | 8.01% | Hold | |
| 6 |
|
927.20K | $948.28M | 7.22% | Add | |
| 7 |
|
4.70M | $908.85M | 6.92% | Add | |
| 8 |
|
16.91M | $855.22M | 6.51% | Add | |
| 9 |
|
717.74K | $427.10M | 3.25% | Hold | |
| 10 |
|
1.59M | $354.58M | 2.70% | Hold | |
| 11 |
|
748.82K | $137.04M | 1.04% | Add | |
| 12 |
|
323.78K | $104.09M | 0.79% | Add | |
| 13 |
|
500.00K | $91.08M | 0.69% | Hold | |
| 14 |
|
7.46M | $58.43M | 0.45% | Hold | |
| 15 |
|
13.96M | $57.10M | 0.43% | Hold | |
| 16 |
|
575.00K | $53.83M | 0.41% | New | |
| 17 |
|
6.92M | $52.34M | 0.40% | Hold | |
| 18 |
|
261.40K | $50.24M | 0.38% | Add | |
| 19 |
|
11.57M | $41.89M | 0.32% | Hold | |
| 20 |
|
38.97M | $38.00M | 0.29% | Hold | |
| 21 |
|
240.00K | $6.08M | 0.05% | Add | |
| 22 |
|
250.00K | $4.07M | 0.03% | Hold | |
| 23 |
|
571.50K | $2.42M | 0.02% | New | |
FAQ
What did Matrix Capital Management Company, LP buy in 2024-Q2?
In its 2024-Q2 13F filing, Matrix Capital Management Company, LP reported 23 equity positions worth $13.14B in aggregate; its largest disclosed positions were NVDA ($3.28B), QCOM ($1.99B), TDG ($1.40B).
How large is Matrix Capital Management Company, LP's portfolio?
Matrix Capital Management Company, LP reported $13.14B of long equity holdings across 23 positions as of 2024-Q2. Top-10 holdings account for 94.7% of reported value.
What is Matrix Capital Management Company, LP's investment style?
HoldingsHub classifies the portfolio as Large / Focused / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.